Loading news...
The Agriculture - Operations industry faces cost pressures and volatility, squeezing margins. Yet innovation and emerging market demand support growth.
SMG teams up with Bonnie Plants and Gardenuity to launch a beginner-friendly patio garden kit, tapping rising interest in homegrown food and sustainability.
Captrust Financial Advisors grew its position in The Scotts Miracle-Gro Company (NYSE: SMG) by 14.5% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,154,815 shares of the basic materials company's stock after acquiring an additional 146,192 shares during the
The momentum is building once again for marijuana stocks. Since the passing of rescheduling cannabis to class 3, investors are staying sharp. Even though this does not legalize cannabis federally, it brings more relaxed investing without stressing federal issues. The cannabis industry has been undergoing another shift due to this. At the same time, this has led more people to find the best marijuana stocks to buy and hold till the market is up.
The U.S. cannabis industry continues expanding despite periods of volatility across the sector. However, ancillary cannabis companies remain essential to the industry's infrastructure. These businesses supply equipment, nutrients, lighting, and hydroponic systems to cannabis cultivators. Because they do not touch the cannabis plant directly, ancillary companies often face fewer regulatory restrictions.
Scotts (SMG) reported earnings 30 days ago. What's next for the stock?
The Scotts Miracle-Gro Company (NYSE: SMG - Get Free Report) Director Hagedorn Partnership, L.P. sold 50,000 shares of the firm's stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $66.40, for a total transaction of $3,320,000.00. Following the sale, the director directly owned 13,167,641 shares of the company's
Calavo Growers (NASDAQ: CVGW - Get Free Report) and Scotts Miracle-Gro (NYSE: SMG - Get Free Report) are both consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership. Analyst Recommendations This is a summary of
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Feb. 11, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor.
Marijuana stocks are still facing a battle in the stock market. The cannabis sector has been fighting to reach higher trading levels more consistently. For some time, there has been significant volatility that has been somewhat challenging for shareholders. You would think that with legal operators showing profitability and overall success, it would follow for the public sector. However, this has not been the case in most instances.
New York State Common Retirement Fund trimmed its position in The Scotts Miracle-Gro Company (NYSE: SMG) by 4.6% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 244,178 shares of the basic materials company's stock after selling 11,679 shares during the period. New York
Scotts Miracle-Gro (NYSE: SMG) used its annual meeting of shareholders to highlight what Chairman and CEO Jim Hagedorn described as a multi-year effort to strengthen the company's financial position while investing for growth. Management also reported that shareholders approved all four proposals on the ballot, including director elections, executive compensation, the auditor ratification and an amended
The cannabis sector continues to evolve as 2026 begins. While plant-touching operators still face regulatory pressure, ancillary companies remain better positioned. These businesses do not grow or sell cannabis directly. Instead, they provide the tools, products, and infrastructure that the industry depends on. As a result, they often carry less regulatory risk. They also tend to survive market downturns more effectively.
The cannabis industry continues to evolve as operators adjust to tighter capital markets and shifting regulations. As a result, many investors are looking beyond plant-touching companies. Ancillary cannabis stocks often provide that alternative exposure. These businesses support the industry without directly selling cannabis. Therefore, they avoid many regulatory and licensing risks. At the same time, they still benefit when cultivation and retail activity improve.
SMG tops Q1 earnings and revenue estimates as adjusted losses narrow, sales beat forecasts, and the company reaffirms its fiscal 2026 outlook.
The Scotts Miracle-Gro Company (SMG) Q1 2026 Earnings Call Transcript
Although the revenue and EPS for Scotts (SMG) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Scotts Miracle-Gro (SMG) came out with a quarterly loss of $0.77 per share versus the Zacks Consensus Estimate of a loss of $1.04. This compares to a loss of $0.89 per share a year ago.
Announces divestiture plan for Hawthorne Unveils new multi-year share repurchase program to commence in late 2026
The sale of Hawthorne Gardening to Vireo Growth reduces Scotts's exposure to the volatile marijuana sector, executives said.